Goat Anti-Mouse IgG H&L preadsorbed (ab7063)
Key features and details
- Goat Anti-Mouse IgG H&L preadsorbed
- Host species: Goat
- Suitable for: ICC/IF, WB, IP, Immunodiffusion, Conjugation, IHC-P, IHC-Fr, ELISA
Related conjugates and formulations
Agarose
Alexa Fluor® 405
Alexa Fluor® 488
Alexa Fluor® 555
Alexa Fluor® 568
Alexa Fluor® 594
Alexa Fluor® 647
Alexa Fluor® 680
Alexa Fluor® 750
Alexa Fluor® 790
Alkaline Phosphatase
APC
beta-galactosidase
Biotin
Cy2 ®
Cy3 ®
Cy5 ®
Cy5.5 ®
DyLight® 488
DyLight® 550
DyLight® 594
DyLight® 650
FITC
Glucose Oxidase
Gold 10nm
Gold 6nm
HRP
HRP polymer
IRDye® 680RD
PE
Texas Red ®
TRITC
Unconjugated
Overview
-
Product name
Goat Anti-Mouse IgG H&L preadsorbed
See all IgG secondary antibodies -
Host species
Goat -
Target species
Mouse -
Tested applications
Suitable for: ICC/IF, WB, IP, Immunodiffusion, Conjugation, IHC-P, IHC-Fr, ELISAmore details -
Minimal
cross-reactivity
Chicken, Cow, Goat, Guinea pig, Hamster, Horse, Human, Rabbit, Rat, Sheep more details -
Immunogen
Full length native Mouse IgG (purified).
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
Storage buffer
Preservative: 0.01% Sodium azide
Constituents: 0.42% Potassium phosphate, 0.87% Sodium chloride -
Concentration information loading... -
Purity
Affinity purified -
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Mouse IgG coupled to agarose -
Clonality
Polyclonal -
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab7063 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| ICC/IF |
1/1000 - 1/5000.
|
|
| WB |
1/2000 - 1/20000.
|
|
| IP |
Use at an assay dependent dilution.
|
|
| Immunodiffusion |
1/5000 - 1/20000.
|
|
| Conjugation |
Use at an assay dependent dilution.
|
|
| IHC-P |
Use at an assay dependent dilution.
|
|
| IHC-Fr |
Use at an assay dependent dilution.
|
|
| ELISA |
1/180000.
|
| Notes |
|---|
|
ICC/IF
1/1000 - 1/5000. |
|
WB
1/2000 - 1/20000. |
|
IP
Use at an assay dependent dilution. |
|
Immunodiffusion
1/5000 - 1/20000. |
|
Conjugation
Use at an assay dependent dilution. |
|
IHC-P
Use at an assay dependent dilution. |
|
IHC-Fr
Use at an assay dependent dilution. |
|
ELISA
1/180000. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
Datasheet download
References (4)
ab7063 has been referenced in 4 publications.
- Zou P et al. Blockage of ERCC6 Alleviates Spinal Cord Injury Through Weakening Apoptosis, Inflammation, Senescence, and Oxidative Stress. Front Mol Biosci 9:853654 (2022). PubMed: 35392536
- Zhao W et al. Angiotensin II receptor type 1 blocker candesartan improves morphine tolerance by reducing morphine‑induced inflammatory response and cellular activation of BV2 cells via the PPARγ/AMPK signaling pathway. Mol Med Rep 26:N/A (2022). PubMed: 36004465
- Wang Q et al. ZC3H13 Inhibits the Progression of Hepatocellular Carcinoma through m6A-PKM2-Mediated Glycolysis and Enhances Chemosensitivity. J Oncol 2021:1328444 (2021). PubMed: 35003256
- Tan S et al. Chlorogenic Acid Promotes Autophagy and Alleviates Salmonella Typhimurium Infection Through the lncRNAGAS5/miR-23a/PTEN Axis and the p38 MAPK Pathway. Front Cell Dev Biol 8:552020 (2020). PubMed: 33240872
